Truncated Erythropoietin Receptors Confer an In Vivo Selective Advantage in Gene-Modified Erythroid Cells Expressing Fetal Hemoglobin Due to BCL11A Interference
Blood (2019) 134 (Supplement_1): 2063.
Currently there are no citedby results. Try again later.
